# A Combination of Abraxane and Cisplatin in Metastatic Breast Cancer

> **NCT01149798** · PHASE2 · COMPLETED · sponsor: **Fudan University** · enrollment: 73 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DRUG:** Abraxane and Cisplatin combination

## Key facts

- **NCT ID:** NCT01149798
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-06
- **Final completion:** 2011-11
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2012-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01149798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01149798, "A Combination of Abraxane and Cisplatin in Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01149798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*